期刊文献+

甲钴胺及叶酸治疗对2型糖尿病同型半胱氨酸硫内酯解酶活性和血浆同型半胱氨酸水平的影响 被引量:22

Effects of intervention therapy of methylcobalamin and folic acid on plasma homocysteine concentration and homocysteine thiolactonase/paraoxonase activity in patients with type 2 diabetes mellitus
原文传递
导出
摘要 目的探讨甲钴胺、叶酸治疗对2型糖尿病患者血浆同型半胱氨酸(Hcy)及同型半胱氨酸硫内酯解酶(HTase/PON)活性的影响。方法 2型糖尿病患者120例,分为4组,每组30例,组Ⅰ:无干预对照组;组Ⅱ:给予叶酸5 mg 口服,1次/日;组Ⅲ:给予甲钻胺500μg肌注,1次/日;组Ⅳ:给予叶酸5 mg+甲钴胺5004μg肌注,1次/日;治疗2周。结果干预组血浆 Hcy 水平比治疗前均显著下降(P<0.05),分别下降为组Ⅳ37.3%,组Ⅲ21.7%,组Ⅱ14.0%,组Ⅰ 2.8%(F=28.894 P=0.000);血清 HTase/PON 活性均显著升高(均 P<0.05),分别升高为组Ⅳ17.6%,组Ⅱ8.0%,组Ⅲ3.4%,组Ⅰ 2.7%(F=36.100,P=0.000)。结论甲钴胺降低血浆 Hcy 作用显著;联合用药对 Hcy及 HTase/PON 的作用显著优于单独用药。叶酸可能通过其抗氧化特性间接影响 HTase/PON 活性。 Objective To study the effects of methylcobalamin and folic acid treatment on plasma homocysteine (Hcy) level and homocysteine thiolactonase/paraoxonase (HTase/PON) activity in patients with type 2 diabetes mellitus. Methods 120 patients with type 2 diabetes mellitus were randomly divided into four equal groups: Group Ⅰ , receiving no intervention therapy as control group,Group Ⅱ , given folic acid orally (5 mg/d), Group Ⅲ, receiving intramuscular injection of methylcobalamin (500 μg qd) , and Group iV, treated with methylcobalamin (500μg qd) in addition to folic acid (5 mg/d) . Forty healthy age-matched persons were used as normal controls. Before and 12 weeks after 2-week treatment, plasma total Hcy, vitamin B12, folic acid, and HTase/PON activity were assayed. Results After 12-week treatment the plasma folic acid and methylcobalamin, and Hcy levels decreased and serum HTase/PON activity increased significantly in the three groups receiving intervention treatment ( all P 〈 0. 05 ). The Hcy level decreased by 2.8% in Group Ⅰ , 14.0% in Group Ⅱ, 37.3% in Group Ⅲ, and 21.. 7% in Group iV respectively ( all P 〈0.01). The HTase/PON activity increased by 2.7% in Group Ⅰ , 8.0% in Group Ⅱ, 3.4% in Group Ⅲ, and 17.6% in Group iV respectively ( all P 〈 0.05). Conclusion Methylcobalamin and folic acid treatment alone can decrease the Hcy level and increase the HTase/PON activity in the patients with type 2 diabetes mellitus, and the methylcobalamin and folic acid combination therapy is much more effective. Folic acid may affect the HTase/PON activity through its antioxidant ability.
出处 《中华医学杂志》 CAS CSCD 北大核心 2007年第4期256-258,共3页 National Medical Journal of China
关键词 糖尿病 半胱氨酸 叶酸 甲钴胺 Diabetes mellitus Cysteine Folic acid Methylcobalamin
  • 相关文献

参考文献10

  • 1Elkhairy L,Ueland PM,Refsum H,et al.Plasma total cysteine as a risk factor for vascular disease:the European Concerted Action Project.Circulation,2001,103:2544-2549.
  • 2Hoogeveen EK,Kostense PJ,Berks PJ,et al.Hyperhomocysteinemia is associated with an increase risk of cardiovascular disease,especially in non-insulin dependent diabetes mellitus:a population based study.Arterioscler Thromb Vasc Biol,1998,18:133-138.
  • 3黄一宁,赵宇岚,李舜伟.同型半胱氨酸和MTHFR基因多态性与缺血性脑血管病的关系[J].中华医学杂志,2002,82(2):119-122. 被引量:54
  • 4谷伟军,郑少雄,陆菊明.对氧磷酸酯酶-1活性在2型糖尿病及血管病变中的改变[J].军医进修学院学报,2005,26(4):285-287. 被引量:1
  • 5Nygard O,Nordrehaud JE,Refsum H,et al.Plasma homocysteine levels and mortality in patients with coronary artery disease.N Engl J Med,1997,337:230-236.
  • 6Selhub J,Jacques PF,Wilson PWF,et al.Vitamin status and intake as primary determinants of homocysteinemia in an elderly population.JAMA,1993,270:2693-2698.
  • 7Janel N,Robert K,Chabert C,et al.Mouse liver paraoxonase-1gene expressionis downregulated in hyperhomocysteinemia.Thromb Haemost,2004,92:221-222.
  • 8Mecknenss B,Durrington PN,Mackness MI,et al.Paraoxonase and coronary heart disease.Curr Opin Lipidol,1998,119:319-324.
  • 9Blundell G,Jones BG,Rose FA,et al.Homocysteine mediated endothelial cell toxicity and its amelioration.Atherosclerosis,1996,122:163-172.
  • 10Huang SR,Hsu Y,Lin HL,et al.Folate depletion and elevated plasma homocysteine promote oxidative stress in rat livers.J Nutr,2001,131:33-38.

二级参考文献12

  • 1黄一宁,高山,王莉鹃,汪波.闭塞性脑血管病经颅多谱勒超声和脑血管造影的比较[J].中华神经科杂志,1997,30(2):98-101. 被引量:176
  • 2袁非综述.糖尿病系视网膜病变及其早期检测[J].国外医学:眼科学分册,2000,24:173-179.
  • 3Mecknenss B, Durrington PN, Mackness MI, et al. Paraoxonase and coronary heart disease[J]. Curr Opin Lipidol,1998, 119: 319-324.
  • 4Hedrick CL, Tiorpe SR. Glycation impairs high density lipoprotein function[J]. Diabetolgia, 2000, 43: 312-320.
  • 5Valabibl J, Avvril J, Li W, et al. High-density lipoprotein composition and paraoxonase activity in type 1 diabetes[J]. Clin Sci, 2001, 101: 659-670.
  • 6Aviram M, Rosenblat M, Billecke S, et al. Human serum paraoxonase(PON1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants[J]. Free Radic Biol Med, 1999, 26: 892-904.
  • 7Mertens A, Holvoet P. Oxidized LDL and HDL: antagonists in atherothrombosis[J]. FASEB J, 2001, 15: 2073-2084.
  • 8Marta T, Mariane S, Ferran GF, et al. Effect of simvastatin therapy on paraoxonase activity and related lipoproteins in familial hypercholesterolemic patients[J]. Arterioscler Thromb Vasc Biol, 2000, 20: 2113-2119.
  • 9Aviram M, Rosenblat M, Billecke S, et al. Paraoxonase inhibits high-density lipoprotein oxidation and preserves its functions. A possible peroxidative role for paraoxonase[J]. Sci Med, 1999, 26: 892-904.
  • 10Hayek T, Fuhrman B, Vaya J, et al. The effect of meals rich in thermally stressed oliver and safflower oils on postprandial serum paraoxonase activity in patients with diabetes[J]. Arterioscler Thromb Vasc Biol,1997,23: 2744-2752.

共引文献53

同被引文献165

引证文献22

二级引证文献167

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部